Publikationen mit Peer Review

Artikel in Zeitschriften mit Peer Review

  • L. Saucedo, I. Pfister, C. Schild, S. Zandi, J. Garweg

    Aqueous Humor Apolipoprotein Concentration and Severity of Diabetic Retinopathy in Type 2 Diabetes.

    10.11.2022, Mediators of Inflammation, 2022:2406322. doi: 10.1155/2022/2406322. PMID: 36405993; PMCID: PMC9671721.
  • J. Garweg, F. Kieffer, L. Mandelbrot, F. Peyron, M. Wallon

    Long-Term Outcomes in Children with Congenital Toxoplasmosis-A Systematic Review.

    15.10.2022, Pathogens, 11(10):1187. doi: 10.3390/pathogens11101187. PMID: 36297244; PMCID: PMC9610672.
  • J. Wons, I. Pfister, S. Anastasi, S. Steinhauer, S. Niderprim, J. Garweg

    Functional Outcome After Macular Hole Surgery: Comparison of Standard Perimetry with Microperimetry

    11.7.2022, Clinical ophthalmology (Auckland, N.Z.), 16:2235-2243. doi: 10.2147/OPTH.S367431. PMID: 35844664; PMCID: PMC9286483
  • A. Bograd, D. Fuchs, J. Bächtiger, I. Pfister, J. Spindler, F. Hoogewoud, K. Gugleta, C. Böni, Y. Guex-Crosier, J. Garweg, C. Tappeiner

    Long-term Efficacy of TNF-alpha Inhibitors on Persistent Uveitic Macular Edema: A Swiss Multicenter Cohort Study.

    19.5.2022, Ocular immunology and inflammation, 1-8. doi: 10.1080/09273948.2022.2075761. Epub ahead of print. PMID: 35588311
  • L. Saucedo, I. Pfister, S. Zandi, C. Gerhardt, J. Garweg

    Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus.

    25.6.2021, Mediators of Inflammation, 2021:9811361. doi: 10.1155/2021/9811361. PMID: 34257518; PMCID: PMC8257377.
  • C. Hänsli, I. Pfister, J. Garweg

    Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes.

    17.6.2021, Journal of Clinical Medicine, 10(12):2666. doi: 10.3390/jcm10122666. PMID: 34204266; PMCID: PMC8235134.
  • A. Baston, C. Gerhardt, S. Zandi, J. Garweg

    Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review.

    20.5.2021, Journal of Clinical Medicine, 10(11):2433. doi: 10.3390/jcm10112433. PMID: 34070857; PMCID: PMC8198854.
  • J. Wons, N. Mihic, I. Pfister, S. Anastasi, J. Garweg, M. Halberstadt

    Effect of Preoperative Intraocular Pressure in Patients with and without Intolerance to Their IOP-Lowering Medication on the Outcome of Trabectome Surgery.

    6.5.2021, Clinical ophthalmology (Auckland, N.Z.), 15:1851-1860. doi: 10.2147/OPTH.S303603. PMID: 33986587; PMCID: PMC8110264.
  • J. Garweg, C. Gerhardt

    Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) – a meta-analysis.

    2.2.2021, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 2021 Aug;259(8):2181-2192. doi: 10.1007/s00417-020-05048-1. Epub ; PMID: 33528645; PMCID: PMC8352813.
  • M. Deiss, C. Kaya, I. Pfister, J. Garweg

    Impact of Vitreal Tamponade on Functional Outcomes in Vitrectomy with ILM Peeling in Primary Macula-Involving Retinal Detachment: A Retrospective Analysis.

    24.12.2020, Clinical ophthalmology (Auckland, N.Z.), 14:4493-4500. doi: 10.2147/OPTH.S287107. PMID: 33380783; PMCID: PMC7769588.
  • I. Pfister, S. Zandi, C. Gerhardt, J. Spindler, N. Reichen, J. Garweg

    Risks and Challenges in Interpreting Simultaneous Analyses of Multiple Cytokines.

    4.6.2020, Translational vision science and technology, 9(7):27. doi: 10.1167/tvst.9.7.27. PMID: 32832233; PMCID: PMC7414671.
  • N. Daftarian, S. Zandi, G. Piryaie, M. Zarif, E. Pirmardan, M. Yamaguchi, Q. Nejad, H. Hasanpour, S. Samiei, I. Pfister, Z. Soheili, S. Nakao, A. Barakat, J. Garweg, H. Ahmadieh, A. Hafezi-Moghadam

    Peripheral blood CD163(+) monocytes and soluble CD163 in dry and neovascular age-related macular degeneration

    30.3.2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020;00: 111. 1902RR
  • C. Kaya, I. Pfister, C. Gerhardt, J. Garweg

    Outcome of treatment for neovascular age-related macular degeneration by practice-based ophthalmologists compared with a macula clinic

    27.3.2020, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, doi:s00417-020-04667-y
  • S. Zandi , F. Freiberg, V. Vaclavik, I. Pfister, P. Traine, C. Kaya, S. Michels, J. Garweg

    Morphological Reconstitution and Persistent Changes After Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole

    22.1.2020, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, DOI: 10.1089/jop.2019.0051
  • J. Garweg , D. Ouassi, I. Pfister

    Hybrid 23/27 Gauge Vitrectomy – Combining the Charm of 27G with the Efficacy of 23G

    2020, Clinical ophthalmology (Auckland, N.Z.), 2020:14 299-305
  • P. Traine, I. Pfister, S. Zandi, J. Spindler, J. Garweg

    Long-term Outcome of Intravitreal Aflibercept Treatment for Neovascular Age-Related Macular Degeneration Using a „Treat-and-Extend“ Regimen

    1.5.2019, Ophthalmology Retina, Volume 3, Number 5, May 2019,
  • S. Zandi, I. Pfister, P. Traine, C. Tappeiner, A. Despont, R. Rieben, M. Skowronska, J. Garweg

    Biomarkers for PVR in rhegmatogenous retinal detachment

    3.4.2019, Public Library of Science, 14(4):e0214674. doi: 10.1371/journal.pone.0214674. eCollection 2019
  • J. Garweg

    Pharmacological treatment strategies and surgical options for uveitis

    22.2.2019, Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, doi: 10.1007/s00347-019-0870-x. [Epub ahead of print] Review. German. PubMed PMID: 30796601
  • J. Garweg, J. Messerli

    Diagnostic Strategy and Therapeutic Dilemma in Acute Posterior and Panuveitis

    14.2.2019, Klinische Monatsblätter für Augenheilkunde, doi: 10.1055/a-0828-7395. [Epub ahead of print]
  • C. Kaya , S. Zandi, I. Pfister, C. Gerhardt, J. Garweg

    Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration

    2019, Clinical ophthalmology (Auckland, N.Z.), 2019:13 2403-2409